Notice Pursuant to the National Cooperative Research and Production Act of 1993-Senior Healthcare Innovation Consortium, 104210 [2024-30405]

Download as PDF 104210 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices Consortium, Inc. (‘‘Subcutaneous Drug Development & Delivery Consortium, Inc.’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Janssen Research & Development, LLC, Malver, PA; Novo Nordisk, Bagsvaerd, DENMARK; and Ypsomed AG, Burgdorf, SWITZERLAND have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Subcutaneous Drug Development & Delivery Consortium, Inc. intends to file additional written notifications disclosing all changes in membership. On October 26, 2020, Subcutaneous Drug Development & Delivery Consortium, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on December 3, 2020 (85 FR 78148). The last notification was filed with the Department on April 25, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on September 12, 2024 (89 FR 74288). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–30418 Filed 12–19–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division ddrumheller on DSK120RN23PROD with NOTICES1 Notice Pursuant to the National Cooperative Research and Production Act of 1993—Senior Healthcare Innovation Consortium Notice is hereby given that, on October 2, 2024 pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Senior Healthcare Innovation Consortium (SHIC) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of VerDate Sep<11>2014 20:12 Dec 19, 2024 Jkt 265001 antitrust plaintiffs to actual damages under specified circumstances. Specifically, AIVOT Robotics, Inc., Seattle, WA; Living Solutions, Afton, WY; Thrive360AI, San Francisco, CA; and Tornado Therapeutics, Boston, MA, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and SHIC intends to file additional written notifications disclosing all changes in membership. On November 2, 2022, SHIC filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on November 23, 2022 (87 FR 71677). The last notification was filed with the Department on July 10, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on September 26, 2024 (89 FR 78902). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–30405 Filed 12–19–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on October 7, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical Technology Enterprise Consortium (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Artery Studios, Inc., Toronto, CANADA; Astek Diagnostics, Inc., Halethorpe, MD; BBC Entrepreneurial Training and Consulting, LLC, Chelsea, MI; Bluestaq, LLC, Colorado Springs, CO; Carrtech Corp., Dickerson, MD; Concept Plus, LLC, Fairfax, VA; Crescel, LLC, Miami Beach, FL; Culmen International, LLC, Alexandria, VA; DeployX Services, Inc., PO 00000 Frm 00139 Fmt 4703 Sfmt 4703 McLean, VA; Digital For Mental Health, Paris, FRANCE; Emvision Medical Devices, Ltd., Macquarie Park, AUSTRALIA; Galapagos Federal Systems, LLC, Kihei, HI; GoDx, Inc., Madison, WI; Government Acquisitions, Inc., Cincinnati, OH; IntelliDyne, LLC, Vienna, VA; IRegained, Inc., Sudbury, CANADA; Northeastern University, Boston, MA; Nytricx, Inc., Athens, GA; Omnix Medical, Jerusalem, ISRAEL; Perfusio Corp., Greenville, NC; Protondx, Ltd., London, UNITED KINGDOM; PSC Biotech Corp., Pomona, CA; Razom, Inc., New York, NY; ReliOx Corp., Jacksonville, FL; SeaStar Medical, Inc., Denver, CO; SPEAR Human Performance, Inc., Tallahassee, FL; SPOC Proteomics, Inc., Scottsdale, AZ; TechWerks, LLC, Arlington Heights, IL; The Neutrino Donut, LLC, Culver City, CA; Unify Medical, Cleveland, OH; University of South Carolina, Columbia, SC; Wearabledose, Inc., Bowie, MD; Zeteo Tech, Inc., Sykesville, MD; and ZuluCare, LLC, Bethpage, NY, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MTEC intends to file additional written notifications disclosing all changes in membership. On May 9, 2014, MTEC filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on June 28, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on September 16, 2024 (89 FR 75566). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–30411 Filed 12–19–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Naval Surface Technology & Innovation Consortium Notice is hereby given that, on October 10, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Naval Surface Technology & Innovation E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Page 104210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30405]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Senior Healthcare Innovation Consortium

    Notice is hereby given that, on October 2, 2024 pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Senior Healthcare Innovation 
Consortium (SHIC) has filed written notifications simultaneously with 
the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Specifically, AIVOT Robotics, Inc., Seattle, WA; Living Solutions, 
Afton, WY; Thrive360AI, San Francisco, CA; and Tornado Therapeutics, 
Boston, MA, have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and SHIC intends to file additional 
written notifications disclosing all changes in membership.
    On November 2, 2022, SHIC filed its original notification pursuant 
to section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to section 6(b) of the Act on 
November 23, 2022 (87 FR 71677).
    The last notification was filed with the Department on July 10, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on September 26, 2024 (89 FR 78902).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-30405 Filed 12-19-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.